| Nome del prodotto |
Miglustat |
| Sinonimi |
(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol; 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2R,3R,4R,5S)-; BuDNJ; Butyldeoxynojirimycin; N-(n-Butyl)deoxynojirimycin; N-Butyldeoxynojirimycin; N-Butylmoranoline; N-butyl-1-deoxynojirimycin; NB-DNJ; OGT 918; SC 48334; SC-48334; SC48334; UNII-ADN3S497AZ; Zavesca; n-Butyl deoxynojirimycin; n-Butyl dnj; 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-; D-Glucitol, 1,5-(butylimino)-1,5-dideoxy-; hydrogen chloride (2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol (1:1:1) |
| Formula molecolare |
C10H22ClNO4 |
| Peso Molecolare |
255.739 |
| InChI |
InChI=1/C10H21NO4.ClH/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12;/h7-10,12-15H,2-6H2,1H3;1H/t7-,8+,9-,10-;/m1./s1 |
| Numero CAS |
72599-27-0 |
| Struttura molecolare |
|
| Punto di ebollizione |
394.7°C at 760 mmHg |
| Punto d'infiammabilità |
215.4°C |
| Simboli di pericolo |
|
| Codici di Rischio |
|
| Sicurezza Descrizione |
|
|
